Skip to main contentSkip to navigation
Sirius Investors
Innate Pharma S.A.

Innate Pharma S.A.

IPHYF
OTCHealthcare

IPHYF Earnings Reports, EPS & Revenue History

Quarterly EPS and revenue vs. estimates for Innate Pharma S.A.. Review beat/miss history, upcoming consensus figures, and earnings call transcripts when available.

EPS and Earnings Announcement

Latest Quarterly EPS
Next Earnings Announcement
Unlock for free

Already registered? Sign in

EPS vs. Estimates

Green band = beat vs estimate · Red band = miss · Lines show actual and consensus EPS.

EPS & Revenue vs. Estimates

Upgrade
DateEPS ActualEPS Est.EPS Diff.
Mar 26, 2026
-0.35-0.350.00
Sep 17, 2025
-0.29-0.33+0.04
May 12, 2025
-0.32-0.26-0.05
Nov 13, 2024
May 14, 2024
Sep 14, 2023
Mar 22, 2023
Nov 13, 2022
May 9, 2022
Oct 26, 2021
May 10, 2021
Nov 16, 2020
May 11, 2020
Nov 12, 2019

Earnings Call Transcripts

Upgrade

Earnings Call Transcripts Require Subscription

Access to earnings call transcripts and AI-powered summaries is available for Pro, Premium, and Enterprise subscribers.

View Pricing Plans

Revenue Breakdown

Want to understand IPHYF's revenue sources? Explore detailed revenue breakdowns by product line and geographic region to see what's driving the company's top line.

View Revenue Breakdown